Quality & Compliance Standards ยท South Sudan
Quality & Compliance Standards ยท South Sudan
Establishing a rigorous pharmaceutical quality management framework aligned with WHO Good Distribution Practices (GDP) and the statutory mandates of the Republic of South Sudan.
Rigorous Analytical Testing & Anti-Counterfeiting
Safeguarding medicine safety, potency, and traceability across the entire transit corridor into South Sudan.
Our prospective operating blueprints are designed in compliance with WHO Technical Report Series guidelines for pharmaceutical distribution. This ensures that every stage of handling—from customs reception at Juba International Airport or Nimule to warehouse sorting and facility dispatch—preserves product stability without mechanical or climatic shock.
Protection of product integrity against humidity, heat, contamination, and unauthorized diversion throughout transit.
South Sudan experiences ambient temperatures exceeding 38°C in dry seasons. To protect sensitive therapeutics, injectables, and biologics, our planned Juba facility incorporates continuous computerized temperature data-loggers, dual backup generator automation, and validated passive thermal shippers for outbound distribution.
Ensuring end-to-end thermal protection even across remote regional routes and extended transit delays.
Substandard and falsified (SF) medical products pose a grave danger to public health in East Africa. Eagles Pharma enforces a strict Zero-Counterfeit policy by accepting only secondary packaging with GS1-compliant 2D data-matrices, tamper-evident seals, and verifiable batch codes traceable to manufacturer master records.
Strict refusal of open-market, unverified, or parallel grey-market pharmaceutical consignments.
Every pharmaceutical manufacturer seeking distribution through Eagles Pharma must undergo formal vendor pre-qualification, including verification of current WHO-GMP certificates, plant audit history, and validation of Common Technical Documents (CTD). Every single batch received requires an original, signed Manufacturer Certificate of Analysis (CoA).
Exclusively partnering with manufacturers who meet international pharmacopeial specifications (USP/BP/Ph.Int).
Our quality management system integrates a post-marketing surveillance desk tasked with recording Adverse Drug Reactions (ADRs) reported by clinical partners. In the event of a quality deviation, our electronic batch ledger allows rapid, targeted product quarantine and recall execution within 24 hours.
Active surveillance protecting patient welfare in accordance with international drug safety covenants.
Adhering to the formal regulatory steps required by the government of the Republic of South Sudan.
Formal entity incorporation under the Ministry of Justice and Constitutional Affairs of the Republic of South Sudan.
Inspection and certification of the central warehouse facility by the Drug and Food Control Authority (DFCA).
Submission and evaluation of manufacturer CTD dossiers and stability assays for every imported product line.
Per-consignment import permits issued by DFCA, verification of CoAs at port of entry, and quarantine batch release.
Eagles Pharma is a proposed pharmaceutical distribution company in its pre-launch stage in South Sudan. Quality assurance frameworks presented represent prospective operating standards currently in development.
Reference: EP-PRQ-2026